Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vibrio species, such as the human pathogen Vibrio cholerae, utilize complex chitin metabolism and chemotaxis pathways to thrive in marine environments and facilitate host colonization (Meibom et al., 2004; PubMed: 15591209). Chitin, a polymer of N-acetylglucosamine, serves as a vital carbon and nitrogen source and acts as a chemical cue that induces natural genetic competence, allowing for horizontal gene transfer (Blokesch, 2012; PubMed: 22435710). The process is initiated by chemotaxis toward chitin sources, mediated by methyl-accepting chemotaxis proteins (MCPs), followed by the secretion of extracellular chitinases like ChiA and ChiB that hydrolyze the polymer (Li & Roseman, 2004; PubMed: 14732680). The resulting chitin oligosaccharides are detected by the hybrid sensor kinase ChiS, which orchestrates the expression of the chitin utilization program and the TfoX-mediated transformation machinery (Watve et al., 2015; PubMed: 25552255). Because these pathways are essential for the environmental persistence and virulence of Vibrio species, they are considered promising targets for the development of novel anti-infective agents (Kirn et al., 2005; PubMed: 15716949). Experimental inhibitors such as allosamidin have been used to study the disruption of chitinase activity, although no clinical drugs currently target this specific pathway in humans. Targeting these systems could potentially reduce the spread of antibiotic resistance and limit the survival of Vibrio pathogens in both the environment and the host.
Inhibition of extracellular chitinase enzymes (e.g., ChiA) to prevent nutrient acquisition and disruption of the ChiS-mediated chitin sensing cascade to inhibit virulence and horizontal gene transfer.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chitin metabolism and chemotaxis pathways in Vibrio species.